Cargando…

Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management

BACKGROUND: Omeprazole, a proton pump inhibitor (PPI), is widely used for the treatment of dyspepsia, peptic ulcer, gastroesophageal reflux disease, and functional dyspepsia. Polypharmacy is common in patients receiving omeprazole. Drug toxicity and treatment failure resulting from inappropriate com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wei, Zeng, Su, Yu, Lu-Shan, Zhou, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671798/ https://www.ncbi.nlm.nih.gov/pubmed/23745048 http://dx.doi.org/10.2147/TCRM.S43151

Ejemplares similares

Drug interaction: Omeprazole and Phenprocoumon
por: Enderle, Christa, et al.
Publicado: (2001)

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy
por: Wang, Zhi-Yu, et al.
Publicado: (2015)

Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
por: Zhou, Yi-Ting, et al.
Publicado: (2013)

Effect of Sijunzi Pills on Pharmacokinetics of Omeprazole in Beagle Dogs by HPLC-UV: A Herb-Drug Interaction Study
por: Xia, Hua-ling, et al.
Publicado: (2021)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
por: Ochoa, Dolores, et al.
Publicado: (2020)

The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients
por: AbdElhalim, Mohamed S., et al.
Publicado: (2020)

Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone
por: Elazzazy, Shereen, et al.
Publicado: (2012)

Concomitant Intake of Coca‐Cola to Manage the Drug–Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy Volunteers
por: van Seyen, Minou, et al.
Publicado: (2019)

Effects of elagolix on the pharmacokinetics of omeprazole and its metabolites in healthy premenopausal women
por: Nader, Ahmed, et al.
Publicado: (2022)

Hypomagnesemia as a potentially life-threatening adverse effect of omeprazole
por: Hansen, Bent-Are, et al.
Publicado: (2016)

Pharmacokinetics and bioequivalence evaluation of omeprazole and sodium bicarbonate dry suspensions in healthy Chinese volunteers
por: Zhang, Rui, et al.
Publicado: (2023)

Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects
por: Groenendaal-van de Meent, Dorien, et al.
Publicado: (2018)

Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer
por: Park, Gab-jin, et al.
Publicado: (2017)

Simultaneous Determination of Loratadine and Its Metabolite Desloratadine in Beagle Plasma by LC-MS/MS and Application for Pharmacokinetics Study of Loratadine Tablets and Omeprazole‑Induced Drug–Drug Interaction
por: Zhang, Yu, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic effects of 2 registered omeprazole preparations and varying dose rates in horses
por: Wise, Jessica C., et al.
Publicado: (2020)

Effect of Laparoscopic Sleeve Gastrectomy on the Pharmacokinetics of Oral Omeprazole Using a Population Approach
por: Chen, Kaifeng, et al.
Publicado: (2022)

Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects
por: Chong, Edward, et al.
Publicado: (2014)

Pharmacokinetic drug-drug interaction and their implication in clinical management
por: Palleria, Caterina, et al.
Publicado: (2013)

Omeprazole-associated rhabdomyolysis
por: Tanaka, Kumiko, et al.
Publicado: (2014)

¿Omeprazol para todos?
por: Sánchez, Diego P., et al.
Publicado: (2014)

The System Profile of Renal Drug Transporters in Tubulointerstitial Fibrosis Model and Consequent Effect on Pharmacokinetics
por: Shi, Birui, et al.
Publicado: (2022)

Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management
por: Feng, Xiu-qin, et al.
Publicado: (2017)

Effect of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Omeprazole Plasma Pharmacokinetics in Healthy Adults
por: Braeckman, Rene A., et al.
Publicado: (2014)

Omeprazole use and risk of chronic kidney disease evolution
por: Guedes, João Victor Marques, et al.
Publicado: (2020)

Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs
por: Cui, Cheng, et al.
Publicado: (2020)

Induction of Erythrocyte Shrinkage by Omeprazole
por: Naveed, Ayesha, et al.
Publicado: (2020)

Buccal Buspirone as add–on Therapy to Omeprazole Versus Omeprazole in Treatment of Gastroesophageal Reflux Diseases (GERD)
por: Abdi, Saeed, et al.
Publicado: (2020)

Evaluation of the effects of medium‐term (57‐day) omeprazole administration and of omeprazole discontinuation on serum gastrin and serum chromogranin A concentrations in the horse
por: Clark, Bethanie, et al.
Publicado: (2023)

Pharmacokinetic and Drug–Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor
por: Garg, Varun, et al.
Publicado: (2019)

Elemental impurities analysis in name-brand and generic omeprazole drug samples
por: Pinheiro, Fernanda C., et al.
Publicado: (2020)

Assessment of Pharmacokinetic Interactions Between Obeticholic Acid and Caffeine, Midazolam, Warfarin, Dextromethorphan, Omeprazole, Rosuvastatin, and Digoxin in Phase 1 Studies in Healthy Subjects
por: Edwards, Jeffrey E., et al.
Publicado: (2017)

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH
por: Iida, Hiroshi, et al.
Publicado: (2012)

Molecular pathways driving omeprazole nephrotoxicity
por: Fontecha-Barriuso, Miguel, et al.
Publicado: (2020)

Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Tamura, Takao, et al.
Publicado: (2012)

Interaction between Omeprazole and Gliclazide in Relation to CYP2C19 Phenotype
por: Dujic, Tanja, et al.
Publicado: (2021)

On the molecular and cellular effects of omeprazole to further support its effectiveness as an antigiardial drug
por: López-Velázquez, Gabriel, et al.
Publicado: (2019)

Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer
por: Zhang, Jin-Liang, et al.
Publicado: (2017)

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)
por: Sakurai, Kouichi, et al.
Publicado: (2012)

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
por: Wedemeyer, Ralph-Steven, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_enpnllkl6bg2ch4d2e0s9p6eoo